EcoDrugPlus

G Protein-Coupled Receptor 119

Ensembl ID : ENSLOCG00000017485
Gene Symbol: GPR119
2 Cross references
171 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSLOCG00000007191
Gene Symbol: GPR84
3 Cross references
113 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLOCG00000005873
Gene Symbol: HCK
3 Cross references
204 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSLOCG00000009833
Gene Symbol: ITK
3 Cross references
207 Possible Orthologues:

Imp (Inosine 5'-Monophosphate) Dehydrogenase 2

Ensembl ID : ENSLOCG00000014390
Gene Symbol: IMPDH2
2 Cross references
200 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSLOCG00000006806
Gene Symbol: JAK1
3 Cross references
235 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSLOCG00000010137
Gene Symbol: JAK2B
1 Cross references
265 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSLOCG00000014166
Gene Symbol: KIT
3 Cross references
272 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSLOCG00000015334
Gene Symbol: KRAS
3 Cross references
207 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLOCG00000005468
Gene Symbol: LYN
3 Cross references
195 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSLOCG00000011876
Gene Symbol: MALT1
3 Cross references
195 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSLOCG00000012245
Gene Symbol: MAPKAPK2
3 Cross references
232 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).